Pfizer is considering selling its hospital drugs unit, formed after the $17 billion acquisition of Hospira in 2015, amid pressure from activist investor Starboard Value. The unit, which includes various sterile injectables, generates around $500 million in annual EBITDA and could be valued at several billion dollars. This move follows a significant decline in Pfizer's market value and ongoing debt reduction efforts, exacerbated by supply disruptions from a tornado that damaged a key manufacturing facility.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.